Ionis Pharmaceuticals (IONS) Capital Leases (2010 - 2011)
Ionis Pharmaceuticals (IONS) recorded quarterly Capital Leases of $656000.0 in Q4 2011, down 15.14% quarter-over-quarter from $773000.0 in Q4 2010, and down 15.14% on a YoY basis from $773000.0 in Q4 2010.
Ionis Pharmaceuticals (IONS) Capital Leases (2010 - 2011) Analysis & Trends
Ionis Pharmaceuticals' Capital Leases history runs 2 years deep, the most recent figure standing at $656000.0 for Q4 2011.
- In Q4 2011, Capital Leases fell 15.14% year-over-year to $656000.0; the TTM figure through Dec 2011 stood at $656000.0 (down 15.14% YoY), while the FY2011 annual figure was $656000.0, down 15.14% from the prior year.
- Capital Leases was $656000.0 for Q4 2011 at Ionis Pharmaceuticals, down from $773000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $773000.0 in Q4 2010 to a low of $656000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ionis Pharmaceuticals | 12.23 Bn | 10.31 Bn | 243.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 656,000.00 |
| Dec 31, 2010 | 773,000.00 |